Jennifer Fox - 13 Jul 2023 Form 3/A - Amendment Insider Report for Apogee Therapeutics, Inc. (APGE)

Role: Director
Signature: /s/ Jane Pritchett Henderson, as attorney-in-fact for Jennifer Fox
Issuer symbol: APGE
Transactions as of: 13 Jul 2023
Net transactions value: $0
Form type: 3/A - Amendment
Filing time: 17 Jul 2023, 17:03:07 UTC
Date Of Original Report: 13 Jul 2023
Previous filing: 13 Jul 2023
Next filing: 03 Jun 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	APGE	Common Stock						34,824	13 Jul 2023	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of 34,824 shares of restricted common stock, one quarter of which will vest on May 26, 2024, with the remaining three quarters vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer.
F2	This amendment is being filed to correct the number of shares reported in Table I due to a calculation error.